NDC 51672-1318-01 - Ciclopirox Olamine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1318
- Requested NDC
- 51672-1318-01
- Package NDCs from labels
- 51672-1318-1, 51672-1318-2, 51672-1318-8, 51672-1318-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc.
- Effective date
- 2026-01-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ciclopirox Olamine Cream USP, 1.0% | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2026-01-16 | HUMAN PRESCRIPTION DRUG LABEL |
| Ciclopirox Olamine Cream USP, 0.77% | RPK Pharmaceuticals, Inc. | 2023-06-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Ciclopirox Olamine Cream USP, 0.77% | NuCare Pharmaceuticals,Inc. | 2021-02-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Ciclopirox Olamine Cream USP, 0.77% | Physicians Total Care, Inc. | 2013-02-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1318-1 | Ciclopirox Olamine | 1 in 1 CARTON | CREAM | 1 | 9 | |
| 51672-1318-1 | Ciclopirox Olamine | 15 g in 1 TUBE | CREAM | 15 | 9 | |
| 51672-1318-2 | Ciclopirox Olamine | 30 g in 1 TUBE | CREAM | 30 | 9 | |
| 51672-1318-2 | Ciclopirox Olamine | 1 in 1 CARTON | CREAM | 1 | 9 | |
| 51672-1318-8 | Ciclopirox Olamine | 90 g in 1 TUBE | CREAM | 90 | 9 | |
| 51672-1318-8 | Ciclopirox Olamine | 1 in 1 CARTON | CREAM | 1 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1318 | CICLOPIROX OLAMINE CREAM [TARO PHARMACEUTICALS U.S.A., INC.] | 5 | Current NDC, Legacy NDC, 6 package rows | 20241222_7fa4032e-a819-4574-b484-c57aaf1c5b01.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-1318-1 | GM - Gram | 51672-1318 | 71b79573-2906-4f5a-8f8a-3db7a79e18e5 | 1 | 2012-07-24 |
| 51672-1318-2 | GM - Gram | 51672-1318 | a1a6a8a4-1338-4eec-a5e0-b370deed22f2 | 1 | 2012-07-24 |
| 51672-1318-8 | GM - Gram | 51672-1318 | 0754035b-bb19-4ce0-9854-ca6ccf2b1266 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Medi-First Plus First Aid Eye Wash | WATER | Unifirst First Aid Corporation | d7ea80ca-b4a0-4476-8b50-b3425c6d456a | 2025-09-08 | Warnings | 059QF0KO0R |
| ECOLAB Eye Wash | PURIFIED WATER | ECOLAB Food Safety Specialties, Inc. | 4bcfa21a-791e-4d04-e054-00144ff88e88 | 2025-09-08 | Warnings | 059QF0KO0R |
| Physicians Care Eyewash | EYEWASH | Acme United Corporation | 3e239b12-9a75-339d-e063-6294a90a72ae | 2025-09-06 | Warnings | 059QF0KO0R |
| Sterile Water | WATER INJECTION | Henry Schein, Inc. | 3501952b-b556-4d5e-b81b-5c35ff87b475 | 2025-08-28 | Warnings, Adverse reactions | 059QF0KO0R |
| Exchange Select Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Army & Air Force Exchange Service | 6c32af3e-5b60-4e3e-95c2-ada37a7d3b2a | 2025-08-22 | Warnings | T5L8T28FGP |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Padagis Israel Pharmaceuticals Ltd | 43826c68-0a20-460d-a7b5-f3e12395a7d0 | 2025-08-22 | Warnings | T5L8T28FGP |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Publix Super Markets Inc | 7b360d3b-fb2b-4f35-a04d-203dd352933d | 2025-08-19 | Warnings | T5L8T28FGP |
| Good Sense Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | L. Perrigo Company | 2492ee1b-01f1-46e7-8790-b6ebc48f2aff | 2025-08-19 | Warnings | T5L8T28FGP |
| DG Health Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Dolgencorp, LLC | d9f12a34-7bd1-4ba5-b34b-1b641f58271a | 2025-08-12 | Warnings | T5L8T28FGP |
| Stye | MINERAL OIL AND PETROLATUM | Insight Pharmaceuticals LLC | f7eb8466-d8ea-4833-9bed-244ead38a3bf | 2025-08-11 | Warnings | T5L8T28FGP |
| LEADER Mineral Oil | MINERAL OIL | Cardinal Health, 110 dba Leader | 7d4f8fa3-8203-5523-e053-2991aa0aba1a | 2025-07-28 | Warnings | T5L8T28FGP |
| Ciclopirox Olamine | CICLOPIROX OLAMINE | Bryant Ranch Prepack | 9130e3c7-566b-411b-b54d-c894e9094b5b | 2025-07-28 | Warnings, Adverse reactions | 50MD4SB4AP |
| Dr Butlers Soothing Incontinence | MINERAL OIL 59.8%, PETROLATUM 36.0% | Beyond Health PA | 3a9d3796-fd05-fe57-e063-6294a90a0ac6 | 2025-07-23 | Warnings | T5L8T28FGP |
| Eyeleve MGD | MINERAL OIL | Bruder Healthcare | 145b66e2-00e1-410e-8539-e12ffc4f6f82 | 2025-07-15 | Warnings | T5L8T28FGP |
| Sterile Water | STERILE WATER | Nephron Pharmaceuticals Corporation | bc04a883-babc-87a6-e053-2995a90a3dfd | 2025-07-11 | Warnings, Adverse reactions | 059QF0KO0R |
| Plaque identifying | PLAQUE IDENTIFYING | Shenzhen Yagao Technology Co., Ltd. | 37eeb656-22f1-7372-e063-6394a90ad041 | 2025-06-19 | Warnings | 059QF0KO0R |
| ProCure Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Twin Med LLC | 37a4cc43-0d53-f1bf-e063-6394a90a2dc9 | 2025-06-15 | Warnings | T5L8T28FGP |
| Hemorrhoidal Pain Relief | HEMORRHOIDAL PAIN RELIEF OINTMENT | Neilmed Pharmaceuticals Inc. | 374d89b6-9305-9adf-e063-6394a90adb32 | 2025-06-11 | Warnings | T5L8T28FGP |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | 4eb3c9ac-268a-5246-e054-00144ff88e88 | 2025-06-09 | Warnings | T5L8T28FGP |
| PRISMASOL BGK2/0 | MAGNESIUM CHLORIDE, DEXTROSE ANHYDROUS, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE, AND POTASSIUM CHLORIDE | Vantive US Healthcare LLC | 7f675fee-8940-4ece-bb0c-75ac79d8708c | 2025-05-31 | Warnings, Adverse reactions | 33X04XA5AT |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.